Skip to main content
Erschienen in: European Journal of Pediatrics 7/2009

01.07.2009 | Original Paper

Quality assessment of clinical practice guidelines for the prevention and treatment of childhood overweight and obesity

verfasst von: Mario Delgado-Noguera, Sera Tort, Xavier Bonfill, Ignasi Gich, Pablo Alonso-Coello

Erschienen in: European Journal of Pediatrics | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

The prevalence of childhood overweight and obesity is increasing at dramatic rates in children and adolescents worldwide. Clinical practice guidelines (CPGs) are “systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.” Their objective is to provide explicit recommendations for clinical practice based on current evidence for best practice in the management of diseases.

Materials and methods

The aim of this study was to identify and assess the quality of CPGs for the prevention and treatment of obesity and overweight in childhood. We developed a search to identify CPGs published between January 1998 and August 2007. We considered for inclusion documents that provided recommendations for clinical practice referring to children and adolescents. Three independent appraisers assessed the quality of the1 CPGs using the AGREE (Appraisal of Guidelines Research and Evaluation) instrument. We identified 376 references and selected 22 for further assessment.

Results

The overall agreement among reviewers using the intraclass correlation coefficient was 0.856 (95% confidence interval [CI] 0.731–0.932). Six of the 22 initial guidelines were recommended and a further eight were recommended with conditions or provisos. We concluded that the number of documents with recommendations on the prevention and treatment of childhood obesity published during the 10-year study period was considerable, but only a few of them could be considered as high quality. CPGs were deficient in areas such as applicability, editorial independence and rigor in development.

Conclusion

Due to the increasing burden of obesity among children and the potential for long-term comorbidities, clinicians need to be critical in assessing the rigor of how these are developed and their appropriateness for use in the clinician’s own practice. There is a need to improve the methodology and the quality of CPGs on childhood obesity to help clinicians and other decision-makers to tackle this disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat AGREE Collaboration (2003) Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 12(1):18–23. doi:10.1136/qhc.12.1.18 CrossRef AGREE Collaboration (2003) Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 12(1):18–23. doi:10.​1136/​qhc.​12.​1.​18 CrossRef
5.
Zurück zum Zitat Berg F, Buechner J, Parham E; Weight Realities Division of the Society for Nutrition Education (2003) Guidelines for childhood obesity prevention programs: promoting healthy weight in children. J Nutr Educ Behav 35(1):1–4. doi:10.1016/S1499-4046(06)60318-7 PubMedCrossRef Berg F, Buechner J, Parham E; Weight Realities Division of the Society for Nutrition Education (2003) Guidelines for childhood obesity prevention programs: promoting healthy weight in children. J Nutr Educ Behav 35(1):1–4. doi:10.​1016/​S1499-4046(06)60318-7 PubMedCrossRef
11.
Zurück zum Zitat Council on Sports Medicine and Fitness and Council on School Health (2006) Active healthy living: prevention of childhood obesity through increased physical activity. Pediatrics 117(5):1834–1842. doi:10.1542/peds.2006-0472 CrossRef Council on Sports Medicine and Fitness and Council on School Health (2006) Active healthy living: prevention of childhood obesity through increased physical activity. Pediatrics 117(5):1834–1842. doi:10.​1542/​peds.​2006-0472 CrossRef
12.
Zurück zum Zitat Cranney A, Waldegger L, Graham ID et al (2002) Systematic assessment of the quality of osteoporosis guidelines. BMC Musculoskeletal Disorders 12:3–20 Cranney A, Waldegger L, Graham ID et al (2002) Systematic assessment of the quality of osteoporosis guidelines. BMC Musculoskeletal Disorders 12:3–20
18.
Zurück zum Zitat Graham ID, Beardall S, Carter AO et al (2001) What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ 165(2):157–163PubMed Graham ID, Beardall S, Carter AO et al (2001) What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ 165(2):157–163PubMed
22.
Zurück zum Zitat Institute of Medicine (1992) Guidelines for clinical practice: from development to use. National Academy Press, Washington, DC Institute of Medicine (1992) Guidelines for clinical practice: from development to use. National Academy Press, Washington, DC
24.
Zurück zum Zitat Kramer MS, Feinstein AR (1981) Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 29:111–123PubMed Kramer MS, Feinstein AR (1981) Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 29:111–123PubMed
25.
Zurück zum Zitat Lama More RA, Alonso Franch A, Gil-Campos M et al; Nutrition Committee of the Spanish Association of Pediatrics (2006) Childhood obesity. Recommendations of the nutrition committee of the Spanish association of pediatrics. Part I. Prevention. Early detection. Role of the pediatrician. An Pediatr (Barc) 65(6):607–615. doi:10.1157/13095854 CrossRef Lama More RA, Alonso Franch A, Gil-Campos M et al; Nutrition Committee of the Spanish Association of Pediatrics (2006) Childhood obesity. Recommendations of the nutrition committee of the Spanish association of pediatrics. Part I. Prevention. Early detection. Role of the pediatrician. An Pediatr (Barc) 65(6):607–615. doi:10.​1157/​13095854 CrossRef
26.
Zurück zum Zitat Lau DC; Obesity Canada Clinical Practice Guidelines Steering Committee and Expert Panel (2007) Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ 176(8):1103–1106. doi:10.1503/cmaj.070306 PubMed Lau DC; Obesity Canada Clinical Practice Guidelines Steering Committee and Expert Panel (2007) Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ 176(8):1103–1106. doi:10.​1503/​cmaj.​070306 PubMed
45.
Zurück zum Zitat Vlayen J, Aertgeerts B, Hannes K et al (2005) A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care 17(3):235–242. doi:10.1093/intqhc/mzi027 PubMedCrossRef Vlayen J, Aertgeerts B, Hannes K et al (2005) A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care 17(3):235–242. doi:10.​1093/​intqhc/​mzi027 PubMedCrossRef
46.
Zurück zum Zitat Whitlock EP, Williams SB, Gold R et al (2005) Screening and interventions for childhood overweight: a summary of evidence for the US Preventive Services Task Force. Pediatrics 116(1):e125–e144. doi:10.1542/peds.2005-0242 PubMedCrossRef Whitlock EP, Williams SB, Gold R et al (2005) Screening and interventions for childhood overweight: a summary of evidence for the US Preventive Services Task Force. Pediatrics 116(1):e125–e144. doi:10.​1542/​peds.​2005-0242 PubMedCrossRef
49.
Zurück zum Zitat Williams CL, Hayman LL, Daniels SR et al (2002) Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106(1):143–160. doi:10.1161/01.CIR.0000019555.61092.9E PubMedCrossRef Williams CL, Hayman LL, Daniels SR et al (2002) Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106(1):143–160. doi:10.​1161/​01.​CIR.​0000019555.​61092.​9E PubMedCrossRef
50.
Zurück zum Zitat Wilson MC, Hayward RS, Tunis SR et al (1995) Users’ guides to the medical literature. VIII. How to use clinical practice guidelines. B. What are the recommendations and will they help you in caring for your patients? The Evidence-Based Medicine Working Group. JAMA 274(20):1630–1632. doi:10.1001/jama.274.20.1630 PubMedCrossRef Wilson MC, Hayward RS, Tunis SR et al (1995) Users’ guides to the medical literature. VIII. How to use clinical practice guidelines. B. What are the recommendations and will they help you in caring for your patients? The Evidence-Based Medicine Working Group. JAMA 274(20):1630–1632. doi:10.​1001/​jama.​274.​20.​1630 PubMedCrossRef
51.
Zurück zum Zitat Woolf SH, Grol R, Hutchinson A et al (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318:527–530PubMed Woolf SH, Grol R, Hutchinson A et al (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318:527–530PubMed
Metadaten
Titel
Quality assessment of clinical practice guidelines for the prevention and treatment of childhood overweight and obesity
verfasst von
Mario Delgado-Noguera
Sera Tort
Xavier Bonfill
Ignasi Gich
Pablo Alonso-Coello
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 7/2009
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-008-0836-5

Weitere Artikel der Ausgabe 7/2009

European Journal of Pediatrics 7/2009 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.